leon-nanodrugs GmbH Revenue and Competitors

„Leading Edge Nanotechnology“ - Innovative Reformulations of Generics Drugs - New Formulations and Combinations of generics and patented drugs “The vision of leon- nanodrugs is to be recognized as a global leader in nano-technology formulated medical drugs through contract services and co-development partnerships, and that it is respected for quality, reliability and development performance by partners, employees and investors.” leon-nanodrugs is a nanotechnology-based drug development company focused on reformulations and reinventions of established drugs. Based on its patented MJR-Nanotechnology-Platform leon-nanodrugs has a leading position in the development of “supergenerics” and “high-barrier-generics”. The company provides a 360 degree service range from scientific concept to GMP manufacturing for pharmaceutical companies all over the world. The business concept includes contract development as well as co-development opportunities. Within a very short development time of three to four years leon-nanodrugs offers a completely new way of product innovations in the worldwide generic market with high return on invest. The supergenerics market has developed in the current pharmaceutical world due to the desire for higher performing APIs coupled with the less stringent and time consuming reformulation (in terms of regulatory approval) required in re-innovating established drugs. More than 60% of all medical drugs used worldwide show a poor solubility (BCS class II or IV, or the combination of both). These molecules are often difficult to formulate using conventional approaches and are associated with innumerable formulation-related performance issues, including; poor bioavailability; lack of dose proportionality; slow onset of action and other attributes leading to poor patient compliance.